Silicic Acid Biocomposite Stabilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods struggle to control and replicate the complex 3D structures of diatom silica, limiting the synthesis of diatom-like forms and hindering the development of synthetic analogues with controlled silica structures for broader applications.
Innovation Solution
A method involving the use of silicic acid to transform biological materials, including cells, into inorganic cell/silica composites that retain biological activity and structure, allowing for the synthesis of stable biocomposites with programmed structures and functions, including the formation of silica replicas and carbonized composites.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Shape
If diatom biomineralization mechanisms are used to synthesize silica structures, then complex 3D architectures with structural control are achieved, but the ability to control and replicate these structures in vitro remains elusive
Solution Approach 1:
The patent uses diatom frustules as natural templates to copy and replicate their complex 3D silica architectures. By employing these biological templates, the invention successfully reproduces diatom-like structures with controlled morphology, overcoming the difficulty of synthesizing such complex forms in vitro without direct biological systems.
Solution Approach 2:
The patent introduces chemical treatments and processing steps as intermediaries to modify and control the silica structures derived from diatom templates. These intermediary processes enable precise control over the final structural properties, bridging the gap between natural template complexity and manufacturable precision.
2Adaptability or versatility
If diatom frustules are used as starting materials for shape-preserving chemical transformations, then functional nanomaterials are produced, but control over silica structure is limited
Solution Approach 1:
The patent systematically varies chemical parameters such as pH, temperature, and reagent concentrations during the transformation processes to achieve precise control over silica structure. By adjusting these parameters, the invention enables both functional versatility and structural precision in the resulting nanomaterials.
Solution Approach 2:
The patent creates composite materials combining diatom frustule structures with various functional components through chemical transformations. This composite approach allows simultaneous achievement of structural control and functional adaptability, as the diatom template provides structural precision while chemical modifications introduce diverse functions.
3Manufacturing precision
If chemical and genetic approaches are used to direct diatom morphology, then some control is achieved, but the process remains challenging
Solution Approach 1:
The patent extracts and utilizes specific chemical pathways and genetic factors that control diatom morphology, separating these critical elements from the complex biological system. By focusing on and manipulating only the essential morphogenetic factors, the invention achieves morphology control without requiring the full complexity of living diatom systems.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the stabilization and preservation of biological materials, allowing them to function in harsh conditions and providing a platform for studying enzymes and tissue regeneration, while also enabling the creation of robust and economical biocomposites with controlled structures and functions.
Implementation Method 1
the use of silicic acid to transform biological materials, including cells, into inorganic cell/silica composites
Implementation Method 2
stabilization and preservation of biological materials, allowing them to function in harsh conditions
Data Source
AI summary
The present invention is directed to the use of silicic acid to transform biological materials, including cellular architecture into inorganic materials to provide biocomposites (nanomaterials) with stabilized structure and function. In the present invention, there has been discovered a means to stabilize the structure and function of biological materials, including cells, biomolecules, peptides, proteins (especially including enzymes), lipids, lipid vesicles, polysaccharides, cytoskeletal filaments, tissue and organs with silicic acid such that these materials may be used as biocomposites. In many instances, these materials retain their original biological activity and may be used in harsh conditions which would otherwise destroy the integrity of the biological material. In certain instances, these biomaterials may be storage stable for long periods of time and reconstituted after storage to return the biological material back to its original form. In addition, by exposing an entire cell to form CSCs, the CSCs may function to provide a unique system to study enzymes or a cascade of enzymes which are otherwise unavailable.